NTV Asset Management »

Vaneck Vectors Pharmaceutical etf shares owned by NTV Asset Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by NTV Asset Management from 13F filings

Historical chart of NTV Asset Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by NTV Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by NTV Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $453k 5.0k 90.70
2022-12-31 $202k 2.6k 77.74
2016-09-30 $278k 4.9k 57.32

More positions owned by NTV Asset Management

SPDR S&P 500 ETF Trust Tr Unit (SPY)
Invesco QQQ Trust Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd Tr S&p500 Eql Wgt (RSP)
iShares Tr Russell 2000 Etf (IWM)
iShares Tr Select Divid Etf (DVY)
iShares Tr Core S&p Mcp Etf (IJH)
Select Sector SPDR Tr Energy (XLE)
iShares Tr Core High Dv Etf (HDV)
NVIDIA Corporation (NVDA)
Select Sector SPDR Tr Indl (XLI)
SPDR Dow Jones Indl Avg ETF Ut Ser 1 (DIA)
SPDR SER Tr Bbg Conv Sec Etf (CWB)

View all positions for NTV Asset Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Northwestern Mutual Wealth Management Company
Miller Investment Management
Prime Capital Investment Advisors
Jpmorgan Chase & Co
Morgan Stanley
LPL Financial
Phoenix Holdings
Avestar Capital
J.Safra Asset Management
Susquehanna International
Citadel Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf